Medication Monitoring for Breast Cancer

This trial tests a new system to help breast cancer survivors adhere to their medication routines. The study employs a smartphone app, a special pillbox tracker, and a fitness tracker to gather data and send reminders. It targets individuals who have had stage 0-3 breast cancer, completed most treatments, and are currently on hormone therapy. Participants must be English-speaking and possess a smartphone. The aim is to determine if this system, called the Integrated Medication Monitoring System, can improve medication adherence over six months. As an unphased trial, it offers participants the chance to contribute to innovative solutions that could enhance medication adherence for breast cancer survivors.

The trial does not specify if you need to stop taking your current medications. However, since it involves monitoring medication adherence for those on endocrine therapy, you will likely continue taking your prescribed endocrine therapy.

Research has shown that digital health tools, such as the medication monitoring system under testing, are generally safe. Various studies have used these tools to assist patients in managing their health and adhering to treatment plans.

For instance, one study examined digital health tools for breast cancer patients and found them effective in improving health outcomes. Although specific safety details for this system are not available, digital tools like these are typically easy to use and safe. They track medication use and send reminders, which are non-invasive and generally safe.

The integrated medication monitoring system is unique because it leverages cutting-edge technology to enhance medication adherence among breast cancer survivors. Unlike traditional treatments that primarily focus on the medication itself, this system uses real-time data from EMA (Ecological Momentary Assessment), MEMS (Medication Event Monitoring System), and Fitbit sensors to track patient behavior and identify those at risk of skipping doses. Researchers are excited about this system because it not only provides personalized reminders through the Digital Trails app but also offers a tailored approach to improve health outcomes by ensuring that patients stick to their prescribed treatment regimens.

Research has shown that a combined medication tracking system can help breast cancer survivors adhere to their treatment plans. This trial will use an integrated medication monitoring system, including alert-based tracking, to assist participants in managing their symptoms more effectively. One study found that such tracking systems improved symptom management for breast cancer patients. Another study discovered that eHealth tools, such as apps and wearable devices, are generally well-received by breast cancer survivors. These tools can remind patients to take their medication, aiding in treatment adherence. While some studies have not yet shown a major improvement in adherence, the personalized approach in this trial, using reminders and tracking, might lead to better results.⁵⁶⁷⁸⁹